ImmunityBio shared a post on X:
“Access to innovative cancer therapies continues to expand. ANKTIVA is now available in Saudi Arabia for patients with bladder and lung cancers, marking an important step in ImmunityBio’s global efforts to reach more patients.
Other articles from ImmunityBio.